Clinical trials
Phase 2 Aspergillosis trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2011 | 1 |
| 2019 | 2 |
| 2020 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 4 |
| Completed | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
| Astellas Pharma Inc | 1 |
| Basilea Pharmaceutica | 1 |
| Pulmatrix Inc. | 1 |
| Scynexis, Inc. | 1 |
| University of Arkansas | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Aspergillosis | 7 |
| Mycoses | 2 |
| Aspergillosis, Allergic Bronchopulmonary | 1 |
| COVID-19 | 1 |
| Granulomatous Disease, Chronic | 1 |
| Invasive Fungal Infections | 1 |
| Invasive Pulmonary Aspergillosis | 1 |
| Lung Diseases, Fungal | 1 |
| Pulmonary Aspergillosis | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.